In this analysis, although the association of obesity with inferior response did not reach statistical significance for IBD (probably due to issues with patient selection and imprecise reporting of data in the included IBD studies), the relationship showed the same trend–in IBD, patients with obesity had 20% higher odds of failing therapy with anti-TNF agents. 74 Assessing trough level of anti-TNF agents, while
← all excerpts
Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries.
1
—
—